A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Sevelamer

Phosphate Binder class · 5 generic manufacturers · 9 ANDAs filed at FDA.

First FDA approval2019-02-08
Generic availableYes · 5 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$24.0M in CY2024 Part D spend38K claims · 13K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.856/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$1.03
Across all dosage forms in distribution.
Highest NADAC
$1.27
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Sevelamer used for?

Sevelamer is a Phosphate Binder medication tracked in Medicare Part D.

Is there a generic for Sevelamer?

Yes. 9 ANDAs filed at FDA, 5 generic manufacturers currently shipping.

How much does my plan pay for Sevelamer?

Across 329 Part D plans, Sevelamer averages $1.03/unit (NADAC). Lowest available: $0.856/unit. Highest in distribution: $1.27/unit.

Is Sevelamer on the FDA shortage list?

No. Sevelamer is not currently on the FDA Drug Shortage Database.

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Phosphate Binder2 alternatives in D1
01
Sevelamer Carbonate
Brand: Renvela
$0.214Lowest NADAC
16Generic mfrs
$181.9MCY24 Part D spend
Compare →
02
Sucroferric Oxyhydroxide
Brand: Velphoro
$17.11Lowest NADAC
0Generic mfrs
$439.3MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.